We supposed that the association between TP53 mutation and poor outcomes of anti-CTLA-4 in melanoma may be partially on account of the down-regulation of FAS mRNA expression by TP53 mutation, impeding CTL-mediated apoptosis of tumor cells. The gene discussed is TP53; the disease is neoplasm.